Antonio Martinez-Ortega, F Javier García-Alonso, Natalia Marcos Carrasco, Amaia Arrubla Gamboa, Lucía Guilabert, Carlos Abril García, Félix Téllez-Avila, José Carlos Subtil Íñigo, Belén Martínez-Moreno, Marina Cobreros Del Caz, Juan J Vila, Vicente Sanchiz Soler, José R Aparicio Tormo, Alejandro Repiso Ortega, José Miguel Esteban, Antonio Velasco-Guardado, Ferrán Gónzalez-Huix, Carlos de la Serna Higuera, Manuel Perez-Miranda
{"title":"Long-Term Clinical Success of Endoscopic Ultrasound-Guided Gastroenterostomy in Benign Gastric Outlet Obstruction.","authors":"Antonio Martinez-Ortega, F Javier García-Alonso, Natalia Marcos Carrasco, Amaia Arrubla Gamboa, Lucía Guilabert, Carlos Abril García, Félix Téllez-Avila, José Carlos Subtil Íñigo, Belén Martínez-Moreno, Marina Cobreros Del Caz, Juan J Vila, Vicente Sanchiz Soler, José R Aparicio Tormo, Alejandro Repiso Ortega, José Miguel Esteban, Antonio Velasco-Guardado, Ferrán Gónzalez-Huix, Carlos de la Serna Higuera, Manuel Perez-Miranda","doi":"10.1111/den.15087","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is an established treatment for malignant gastric outlet obstruction (GOO). Data on EUS-GE for benign GOO (bGOO) are limited. This study aimed to evaluate long-term clinical outcomes of EUS-GE in bGOO.</p><p><strong>Methods: </strong>Retrospective study on consecutive patients who underwent EUS-GE for bGOO using lumen apposing metal stents (LAMS) at 9 Spanish centers. The primary outcome was the ability to regain and maintain oral feeding. Secondary outcomes included technical success, immediate clinical success, LAMS dysfunction, and adverse event rates.</p><p><strong>Results: </strong>Sixty-two patients (75.8% male) with a median age of 65 years (56.9-74) were included. Most cases of bGOO were related to chronic (35.5%) or acute (24.2%) pancreatitis. Technical success was achieved in 61 (98.4%), and immediate clinical success in 57 (91.9%) patients. Among patients reaching immediate clinical success, the median LAMS indwell time was 505 (201-848) days. LAMS dysfunction developed in 7 (12.3%) patients after a median of 1200 (IQR: 94-1568) days. Oral feeding at 24 months was maintained in 85.3% patients overall and in 93.6% patients among those with immediate clinical success. Seven adverse events, including a fatal aspiration pneumonia and a fatal delayed bleeding, occurred in 6 (9.7%) patients.</p><p><strong>Conclusions: </strong>EUS-GE has a high immediate clinical success rate in patients with bGOO and a low risk of stent dysfunction.</p><p><strong>Trial registration: </strong>Promotor center identification number: PI-24-448-H.</p>","PeriodicalId":72813,"journal":{"name":"Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/den.15087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims: Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is an established treatment for malignant gastric outlet obstruction (GOO). Data on EUS-GE for benign GOO (bGOO) are limited. This study aimed to evaluate long-term clinical outcomes of EUS-GE in bGOO.
Methods: Retrospective study on consecutive patients who underwent EUS-GE for bGOO using lumen apposing metal stents (LAMS) at 9 Spanish centers. The primary outcome was the ability to regain and maintain oral feeding. Secondary outcomes included technical success, immediate clinical success, LAMS dysfunction, and adverse event rates.
Results: Sixty-two patients (75.8% male) with a median age of 65 years (56.9-74) were included. Most cases of bGOO were related to chronic (35.5%) or acute (24.2%) pancreatitis. Technical success was achieved in 61 (98.4%), and immediate clinical success in 57 (91.9%) patients. Among patients reaching immediate clinical success, the median LAMS indwell time was 505 (201-848) days. LAMS dysfunction developed in 7 (12.3%) patients after a median of 1200 (IQR: 94-1568) days. Oral feeding at 24 months was maintained in 85.3% patients overall and in 93.6% patients among those with immediate clinical success. Seven adverse events, including a fatal aspiration pneumonia and a fatal delayed bleeding, occurred in 6 (9.7%) patients.
Conclusions: EUS-GE has a high immediate clinical success rate in patients with bGOO and a low risk of stent dysfunction.
Trial registration: Promotor center identification number: PI-24-448-H.